ObsEva SA (OBSV) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction

ObsEva SA (OBSV) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for woman’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.